PTH Human Recombinant (Highly Pure)

<strong>PTH Human Recombinant</strong>_x000D_ <strong>Catalog number:</strong> B2010217_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Volume/Weight:</strong> 50 ug_x000D_ <strong>pH:</strong> na_x000D_ <strong>Supplied as:</strong> Ready-to-use_x000D_ <strong>Appearance:</strong> Lyophilized_x000D_ <strong>Applications:</strong> recombinant human parathyroid hormone, suitable for many biochemical and assay development applications._x000D_ <strong>Storage:</strong> -20C_x000D_ <strong>Keywords:</strong> parathyroid hormone, parathormone_x000D_ <strong>Grade:</strong> Biotechnology grade. All components are highly pure (minimum 99%). All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered on a 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Zhang D, Potty A, Vyas P, Lane J. The role of recombinant PTH in human_x000D_ fracture healing: a systematic review. J Orthop Trauma. 2014 Jan;28(1):57-62._x000D_ _x000D_ 2: Deal C, Gideon J. Recombinant human PTH 1-34 (Forteo): an anabolic drug for_x000D_ osteoporosis. Cleve Clin J Med. 2003 Jul;70(7):585-6, 589-90, 592-4 passim._x000D_ _x000D_ 3: Tabacco G, Bilezikian JP. New Directions in Treatment of Hypoparathyroidism._x000D_ Endocrinol Metab Clin North Am. 2018 Dec;47(4):901-915._x000D_ _x000D_ 4: Jung J, Yoo HY, Kim GT, Lee JW, Lee YA, Kim DY, Kwon YD. Short-Term_x000D_ Teriparatide and Recombinant Human Bone Morphogenetic Protein-2 for Regenerative_x000D_ Approach to Medication-Related Osteonecrosis of the Jaw: A Preliminary Study. J_x000D_ Bone Miner Res. 2017 Dec;32(12):2445-2452._x000D_ _x000D_ 5: Ramakrishnan Y, Cocks HC. Impact of recombinant PTH on management of_x000D_ hypoparathyroidism: a systematic review. Eur Arch Otorhinolaryngol. 2016_x000D_ Apr;273(4):827-35._x000D_ _x000D_ 6: Warden SJ, Komatsu DE, Rydberg J, Bond JL, Hassett SM. Recombinant human_x000D_ parathyroid hormone (PTH 1-34) and low-intensity pulsed ultrasound have_x000D_ contrasting additive effects during fracture healing. Bone. 2009_x000D_ Mar;44(3):485-94._x000D_ _x000D_ 7: Frolik CA, Cain RL, Sato M, Harvey AK, Chandrasekhar S, Black EC, Tashjian AH_x000D_ Jr, Hock JM. Comparison of recombinant human PTH(1-34) (LY333334) with a_x000D_ C-terminally substituted analog of human PTH-related protein(1-34) (RS-66271):_x000D_ In vitro activity and in vivo pharmacological effects in rats. J Bone Miner Res._x000D_ 1999 Feb;14(2):163-72._x000D_ _x000D_ 8: Pines M, Adams AE, Stueckle S, Bessalle R, Rashti-Behar V, Chorev M,_x000D_ Rosenblatt M, Suva LJ. Generation and characterization of human kidney cell_x000D_ lines stably expressing recombinant human PTH/PTHrP receptor: lack of_x000D_ interaction with a C-terminal human P TH peptide. <a href="https://pubmed.ncbi.nlm.nih.gov/7925136/">Endocrinology.</a> 1994_x000D_ Oct;135(4):1713-6._x000D_ _x000D_ <strong>Products Related to PTH Human Recombinant: </strong><a href="https://moleculardepot.com/product-category/proteins/">Proteins</a>